The North America Clinical Data Analytics In Healthcare Market size is estimated at USD 12.85 billion in 2024, and is expected to reach USD 16.51 billion by 2029, growing at a CAGR of 14.43% during the forecast period (2024-2029).
Clinical data analysis within the medical field is critical to address and prevent disease, improve quality of care, and avoid avoidable deaths due to certain chronic diseases.
North America clinical data analytics in the healthcare market is a competitive market that has gained traction in recent years. Few big firms presently dominate the industry in terms of market share. These market leaders are concentrating their efforts on growing their consumer base to include international countries. These businesses are making use of strategic collaboration efforts to expand their market share and profits.
In June 2023, TheMathCompany, an Illinois-headquartered global data analytics and engineering company, partnered with the healthcare technology company Komodo Health. TheMathCompany is expected to leverage this collaboration with Komodo and its enhanced artificial intelligence capabilities to support a range of patient and healthcare provider use cases for its customers, from clinical development and commercial teams to medical affairs and HEOR business functions within the pharmaceutical industry.
In October 2022, McKesson completed a transaction with HCA Healthcare Inc. In order to improve the accessibility and availability of clinical trials, this company is developing an oncology research business combining McKesson US Oncology Research with HCA Sarah Cannon Research Institute, one of the largest cancer research organizations in the world.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook